Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: an expert consensus summary statement from the GCC vitamin D advisory board.

Mona A Fouda, Nasser Al-Daghri, Shaun Sabico, Waleed Al-Baker, Tarik Elhadd, Neil Gittoes, Nasreen Al-Sayed, Naji Aljohani, Nadia Al Ali, Yousef Al Saleh, Mohammed Hassanein, Essa Al-Dhafiri, Ebtesam Ba-Essa, Ali Al Mamari, Ahmed Hassoun, Abdulrazzaq Almadani, Wiam Hussein, Salem A Beshyah

Journal: Archives of osteoporosis 2020;15(1):35

PMID: 32124080

Full Text on Springer View on PubMed

Abstract

OBJECTIVE

A summary of recommendations is given within the Gulf Cooperation Council (GCC) setting on the assessment and management of vitamin D deficiency in the region.

METHODS

An assembly of 11 regional experts gathered to formulate an all-inclusive approach to vitamin D deficiency within GCC.

RESULTS AND CONCLUSION

Several gaps were identified before regional guidelines could be developed. These include adequacy and standardization of vitamin D testing, frequency of repeated testing and reference ranges, distinguishing prevention from the treatment of vitamin D deficiency, quality assurance of vitamin D products sold within GCC including contents and origins of products, and cut-points for vitamin D levels in local populations. A platform is created that can be further developed for overall regional implementation.

Address: College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. [email protected].; King Abdullah International Medical Research centre, Riyadh, Saudi Arabia. [email protected].; Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia. [email protected].; Biochemistry Department, Chair for Biomarkers of Chronic Diseases, College of Science, King Saud University, Riyadh, Saudi Arabia. [email protected].; Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates.; Department of Diabetes and Endocrinology, Mediclinic Airport Road, Abu Dhabi, United Arab Emirates.; Dr Wiam Clinic, Royal Bahrain Hospital, Manama, Kingdom of Bahrain.; Alborj Medical Centre, Dubai, United Arab Emirates.; Dubai Diabetes Centre, Dubai Health Authority, Dubai, United Arab Emirates.; Sultan Qaboos University Hospital, Muscat, Oman.; Diabetes and Endocrine Centre, Dammam Medical Complex, Dammam, Saudi Arabia.; Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.; Alalam Medical centre, Riyadh, Saudi Arabia.; Department of Diabetes and Endocrinology, Dubai Health Authority, Dubai Hospital, Dubai, United Arab Emirates.; Department of Medicine, Division of Endocrinology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Unit of Endocrinology & Metabolism, Amiri Hospital, Kuwait City, Kuwait.; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; Biochemistry Department, Chair for Biomarkers of Chronic Diseases, College of Science, King Saud University, Riyadh, Saudi Arabia.; Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia.; Gulf Medical and Diabetes Centre, Manama, Bahrain.; Department of Endocrinology, University Hospitals Birmingham and University of Birmingham, Birmingham, UK.; Hamad Medical Corporation, Endocrine Section, Qatar Metabolic Institute, Doha, Qatar.

DOI: 10.1007/s11657-020-0709-8

Link outs

Free resources

Medical:

https://medlineplus.gov/vitaminddeficiency.html

Subscription / membership required

Full Text Sources:

https://dx.doi.org/10.1007/s11657-020-0709-8

MeSH Terms: Advisory Committees, Consensus, Disease Management, Humans, Indian Ocean, Practice Guidelines as Topic, Reference Values, Vitamin D, Vitamin D Deficiency